PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016

20 June, 2016

BOSTON, June 20, 2016— PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52ndAnnual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia.